NCT05688995 is a clinical trial of Naser Al-Husban in Menstrual Irregularity, sponsored by University of Jordan.

Who is sponsoring NCT05688995?

NCT05688995 is sponsored by University of Jordan.

What drugs are being tested in NCT05688995?

Interventions in NCT05688995: Naser Al-Husban.

What condition does NCT05688995 study?

NCT05688995 studies Menstrual Irregularity.

Is NCT05688995 still recruiting?

NCT05688995 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT05688995

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Vaccines and the Menstrual Cycle

Completed Last updated 18 January 2023

What this trial tests

trial testing Naser Al-Husban in Menstrual Irregularity in 617 participants. Completed in 1 January 2023.

Timeline

30 September 2021

Primary endpoint
30 December 2021

1 January 2023

Quick facts

Lead sponsor	University of Jordan
Status	Completed
Study type	OBSERVATIONAL
Enrollment	617
Start date	30 September 2021
Primary completion	30 December 2021
Estimated completion	1 January 2023
Sites	1 location across Jordan

Drugs / interventions tested

Naser Al-Husban — full drug profile →

Conditions studied

Menstrual Irregularity — all drugs for Menstrual Irregularity →

Sponsor

University of Jordan

Who can join

Adults 18 to 40, female only, with Menstrual Irregularity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aimed to explore the effect of different COVID-19 vaccines on menstrual cycle

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Naser Al-Husban

Trials testing the same drug.

NCT04726865 — COVID-19 Pandemic and Medical Students · completed
NCT05595512 — Postpartum Depression · completed

Other recruiting trials for Menstrual Irregularity

Currently open trials in the same condition.

NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT06471582 — Timing of Energy Availability on Menstrual Cycle Function · NA · recruiting
NCT06768879 — Sonographic Evaluation Of Uterine Fibroids At Different Locations In Patient With Irregular Menstrul Cycle · active not recruiting

Other University of Jordan trials

Trials by the same sponsor.

NCT07370545 — Impact of Presentation Sequence on Patient Tooth Shade Selection · NA · completed
NCT07279285 — Sweet-Tasting Solution Versus Placebo to Reduce Pain During Local Anesthetic Injection in Children · NA · not yet recruiting
NCT07310485 — Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa · NA · enrolling by invitation
NCT06977009 — Influence of Occlusal Reduction on Endodontic Postoperative Pain · NA · recruiting
NCT07212413 — Effect of Snow-plow Technique on the Postoperative Pain Following Direct Composite Restoration · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05688995 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Jordan
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05688995.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing